Insider Transactions in Q1 2023 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
2,102
+6.1%
|
-
|
|
Feb 01
2023
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,438
-4.89%
|
$494,672
$344.15 P/Share
|
|
Feb 01
2023
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,154
+9.69%
|
-
|
|
Feb 01
2023
|
Michael B Mason EVP & Pres., Lilly Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
2,935
-8.58%
|
$1,009,640
$344.15 P/Share
|
|
Feb 01
2023
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
6,690
+16.36%
|
-
|
|
Feb 01
2023
|
Anat Hakim EVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,393
-20.55%
|
$1,167,192
$344.15 P/Share
|
|
Feb 01
2023
|
Anat Hakim EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,646
+31.65%
|
-
|
|
Feb 01
2023
|
Patrik Jonsson EVP&Pres, LLY Dia&Obe, LLY USA |
SELL
Payment of exercise price or tax liability
|
Direct |
2,997
-7.88%
|
$1,030,968
$344.15 P/Share
|
|
Feb 01
2023
|
Patrik Jonsson EVP&Pres, LLY Dia&Obe, LLY USA |
BUY
Exercise of conversion of derivative security
|
Direct |
6,690
+14.95%
|
-
|
|
Feb 01
2023
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,359
-5.17%
|
$7,347,496
$344.15 P/Share
|
|
Feb 01
2023
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,786
+10.37%
|
-
|
|
Jan 17
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.87%
|
$4,998
$357.74 P/Share
|
|
Jan 17
2023
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.01%
|
$2,142
$357.74 P/Share
|
|
Jan 17
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+4.51%
|
$9,996
$357.74 P/Share
|
|
Jan 17
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.27%
|
$14,280
$357.74 P/Share
|
|
Jan 17
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+1.34%
|
$9,639
$357.74 P/Share
|
|
Jan 17
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.04%
|
$9,996
$357.74 P/Share
|
|
Jan 17
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.06%
|
$11,424
$357.74 P/Share
|